Diamond Biofund Inc. (TPE:6901)
Taiwan · Delayed Price · Currency is TWD 16.15
-0.40 (-2.42%)
Aug 28, 2026, 1:30 PM CST
Diamond Biofund Revenue
Diamond Biofund had revenue of 3.47B TWD in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to 3.02B. In the year 2025, Diamond Biofund had annual revenue of -1.07B.
Revenue (ttm)
3.02B
Revenue Growth
n/a
P/S Ratio
4.56
Revenue / Employee
104.27M
Employees
29
Market Cap
13.78B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | -1.07B | 1.16B | - |
| Dec 31, 2024 | -2.23B | 210.73M | - |
| Dec 31, 2023 | -2.44B | -3.46B | - |
| Dec 31, 2022 | 1.02B | -2.05B | -66.85% |
| Dec 31, 2021 | 3.06B | -3.44B | -52.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Cathay Financial Holding | 1.19T |
| Fubon Financial Holding | 1.05T |
| CTBC Financial Holding | 558.14B |
| Mercuries & Associates Holding | 146.13B |
| TS Financial Holding | 129.67B |
| China Man-Made Fiber | 45.65B |
| Concord Securities | 9.42B |
| Taiwan Fire & Marine Insurance | 7.39B |